In 2013, several groups identified WNT1 as a key ligand to the WNT pathway in bone; heterozygous WNT1 mutations were reported to cause autosomal dominant osteoporosis, and homozygous mutations, a more severe osteogenesis imperfecta (55). Here, WNT1 is linked to osteogenesis imperfecta.